Clouds of Care

Ghent, BelgiumFounded 201611–50 employeescloudsofcare.comLinkedIn

EEG and neural monitoring

Clouds of Care is a digital health company focused on improving CNS clinical development through objective neurophysiological endpoints. Its multimodal AI-powered biomarker platform and clinical trial services help partners use electrophysiology and other digital health technologies across CNS indications.

Visit cloudsofcare.com ↗

Founded: 2016
Employees: 11–50

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Clouds of Care’s clearest recent milestone was its Oct 29, 2025 partnership with Indivi. The collaboration combines Clouds of Care’s neuro-electrophysiology capabilities with Indivi’s digital health tools to support precision therapies and deeper phenotyping in Parkinson’s disease. This extends the company’s clinical-development focus beyond standalone EEG analysis toward multimodal biomarker programs for central nervous system disorders. The company also reached a financing and governance milestone on Sep 4, 2024, when it secured €5 million, equivalent to approximately $5.54 million, from TCD Capital, Flanders Future Tech Fund, and White Fund. The financing was accompanied by the appointment of Michel Vounantsos, former Biogen CEO, as chairman of the board. The 2025 Indivi relationship is the strongest public indicator of commercial ecosystem expansion, while the 2024 financing appears to have supported broader CNS healthcare innovation and executive strengthening.

Market position

Clouds of Care operates at the intersection of clinical research, medical devices, digital health, and neuroscience rather than competing solely as a conventional clinical research provider. Its differentiation is the use of objective neurophysiological endpoints, including EEG and electrical source imaging, to help sponsors detect and interpret treatment effects in CNS trials. The company also combines electrophysiology with clinical and biological data, multimodal analytics, and home-based measurement capabilities. Its product set includes Epilog, Persyst ESI powered by Epilog, and Sleep Insights, giving it relevance across epilepsy, sleep disorders, neurodegeneration, and broader neurological development. Relative to generic digital health vendors, Clouds of Care has a narrower CNS specialization and a stronger emphasis on regulated neurophysiology. Relative to traditional trial-service organizations, its potential advantage is earlier signal detection through disease-relevant biomarkers. The €5 million 2024 financing and 2025 Indivi partnership indicate an effort to build an integrated precision-medicine platform rather than remain a single-purpose EEG services business.

Growth & opportunities

Clouds of Care’s trajectory shows a progression from specialized neurophysiology services toward a broader technology-enabled clinical development platform. Founded in 2016, the company initially centered its offering on EEG analysis for epilepsy, sleep, and other neurological conditions through Epilog. Its current positioning adds multimodal AI-powered biomarkers, digital health technologies, and integration of real-time brain-function data with clinical and biological information. A 2019 co-CEO hiring signal indicated an early effort to add senior healthcare leadership. The major financial inflection point was the €5 million round announced on Sep 4, 2024, with TCD Capital, Flanders Future Tech Fund, and White Fund participating; this corresponds to approximately $5.54 million. Governance also strengthened when Michel Vounantsos became chairman. On Oct 29, 2025, the Indivi partnership broadened the company’s reach into deep phenotyping for Parkinson’s and related CNS drug development.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Clouds of Care distinct

reccy insights

What makes Clouds of Care distinct

01Focuses on objective, meaningful neurophysiological endpoints to improve CNS clinical development.
02Enables non-invasive electrophysiology measurement in patients’ homes.
03Combines scientists, clinicians, engineers, software developers, and regulatory specialists in a multidisciplinary team.
04Brings experience spanning epilepsy, sleep disorders, neurodegeneration, and broader CNS applications.
05Offers regulated and certified capabilities, including an FDA-cleared and CE-marketed SaMD and ISO-certified quality and information security systems.

Technology & products

Epilog
Provides EEG analysis services to aid in monitoring and interpreting EEG data for epilepsy, sleep, and other neurological conditions.

Multimodal AI-powered biomarker platform
Electrophysiology and EEG signal processing
Persyst ESI powered by Epilog, an FDA-cleared and CE-marketed SaMD for electrical source imaging
Sleep Insights, a PSG-analysis solution for sleep disorders
Digital health technology solutions for CNS clinical trials

Recent updates1

Launches, partnerships and team changes from press coverage

Oct 29, 2025Partnership
Clouds of Care and Indivi formed a partnership combining neuro-electrophysiology and digital health tools to develop precision therapies for Parkinson’s.
labiotech.eu

Similar companies

Show all 6 companies

About Clouds of Care

Products: Epilog
Leadership: Michel Vounantsos, Chairman of the Board
Focus areas: Digital health, AI/ML, neuroscience, clinical research, CNS, EEG, biomarkers, medical devices
Headquarters: Ghent, Belgium
Founded: 2016
Employees: 11–50